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ABSTRACT
Objectives: The EuroQol (EQ-5D) and SF-6D (derived from
the SF-12) were compared to assess any ceiling effect in the
EQ-5D and the SF-6D descriptive systems. In addition, the
Physical Component Summary (PCS-12), the Mental Com-
ponent Summary (MCS-12) and the EuroQol Visual Analog
Scale (EQ-VAS) were compared on their discriminative abil-
ity to detect differences among individuals with different
morbidities and sociodemographic characteristics.
Methods: Data from the 2000 Medical Expenditure Panel
Survey were used for the analysis. A total of 11,248 individ-
uals that were 18 years or older and had data on all the study
variables were included in the analysis.
Results: A total of 5104 individuals (47%) reported no lim-
itations on all of the EQ-5D dimensions and only 683 (5.8%)
were classified in full health based on the SF-6D descriptive
system. Approximately 49% of the respondents that
reported no limitations on the EQ-5D reported feeling “tense
or downhearted and low,” “a little,” (level 2) or “some”
(level 3) of the time on SF-6D. PCS-12 scores and EQ-VAS
scores among individuals reporting no limitations on the EQ-
5D descriptive system were significantly lower for respond-
ents reporting coronary heart disease, angina, diabetes,
myocardial infarction, high blood pressure or joint pain com-
pared with respondents that reported no medical condition.
Effect sizes for medical conditions using the PCS-12 were
larger than the effect sizes using the EQ-VAS.
Conclusions: Unlike the EQ-5D descriptive system, the SF-
6D descriptive system derived from the SF-12 does not seem
to have a ceiling effect. Nevertheless, the SF-6D does not dis-
criminate between individuals with different morbidities who
report full health on the EQ-5D, as does the PCS-12 and the
EQ-VAS.
Keywords: ceiling, EQ-5D, EuroQol, SF-12, SF-6D.
Introduction
The 12-item Short Form Health Survey (SF-12) and the
EuroQol (EQ-5D) are easy to administer generic
health-related quality of life measures that are widely
used in population surveys, clinical practice, and clin-
ical trials [1–4]. The EQ-5D index is a preference-
based index measure, where an individual provides an
assessment of each component of his/her health status
according to a structured health-status classification
system and a single preference-based score is derived
for each individual based on societal preferences [5]. In
contrast, the SF-12 and the EuroQol Visual Analog
Scale (EQ-VAS) that is included in the EQ-5D as a sep-
arate measure to assess health-related quality of life
(HRQOL) do not assign an external value to individ-
uals’ assessments of their health. The EQ-VAS contains
one item that assesses individuals’ self-rated health sta-
tus, whereas, the SF-12 generates summary scores that
are psychometrically derived [5].
The advantage with preference-based index meas-
ures is  the  ability  to  obtain  a  single  index  score  for
an individual that can be used to calculate quality-
adjusted life-years. Brazier et al. provided an algorithm
to derive a preference-based single index score, SF-6D
index, from the 36-item Short Form Health Survey
(SF-36) [6]. Nevertheless, because the respondent bur-
den with the 12-item SF-12 is substantially lower com-
pared with  the  respondent  burden  with  the  36-item
SF-36, there is growing use of the SF-12 instrument
among researchers. As a result, recently, Brazier and
Roberts provided an algorithm to derive SF-6D from
the SF-12 [7]. The SF-6D derived from the SF-12 varies
from the SF-6D derived from the SF-36 in some
aspects. The SF-6D derived from the SF-36 uses 11
items from the SF-36, whereas the SF-6D derived from
the SF-12 uses seven items from the SF-12. The phys-
ical functioning domain in the SF-6D derived from the
SF-12 contains three levels compared with six levels in
the SF-6D derived from the SF-36. There is also one
less level in the pain domain of SF-6D derived from SF-
12 as compared with the SF-6D derived from SF-36
(five levels vs. six levels, respectively).
Previous studies have compared the EQ-5D and the
SF-6D derived from the SF-36 [8–11]. Brazier et al.
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found  an  interclass  correlation  of  0.51  between  the
SF-6D and the EQ-5D [11]. They also found some evi-
dence of ceiling effects in the EQ-5D descriptive sys-
tem. In their analysis, they found 214 observations
where patients reported full health on the EQ-5D, of
which only 12 (6%) were classified in full health on the
SF-6D. Similar comparison between the SF-6D derived
from the SF-12 and the EQ-5D are not available.
The purpose of this analysis was to compare the
EQ-5D and the SF-6D derived from the SF-12 to
examine any ceiling effects in the EQ-5D and the SF-
6D descriptive systems in the US general population. In
addition, the study explored the discriminative ability
of SF-12 component summary scores and the EQ-VAS
to discriminate between individuals with various med-
ical conditions and different sociodemographic char-
acteristics among individuals reporting full health on
the EQ-5D or the SF-6D descriptive systems. Our
study hypotheses were that the EQ-5D descriptive sys-
tem would have a ceiling effect in the US general pop-
ulation [11–14] and the SF-12 component summary
scores would have better discriminative ability than
the one-item EQ-VAS in differentiating between indi-
viduals with various medical conditions and different
sociodemographic characteristics among individuals
reporting full health on the EQ-5D or the SF-6D
descriptive systems [15].
Methods
Data Source
The data used for analysis were taken from the house-
hold component of the 2000 Medical Expenditure
Panel Survey (MEPS) conducted by the Agency for
Healthcare Research and Quality [16]. The household
component survey was a year long panel survey of
25,096 persons representative of the civilian, noninsti-
tutionalized US population [16]. The survey used a
stratified multistage area probability design with over
sampling of African Americans and Hispanic persons.
The MEPS is a panel survey, with an overlapping
cohort design. A new cohort is initiated each year and
provides information for a 2-year reporting period.
The MEPS involves five in-person interviews with one
or more persons per household, who report on health-
care utilization, expenditures, insurance coverage, and
medical conditions for each household member. Cross-
sectional analyses combine information from two
cohorts. The EQ-5D and SF-12 scores for this study
were collected in 2000, representing round two of data
collection for the 2000 cohort and round four of data
collection for the 1999 cohort.
The survey also gathered data on sociodemographic
characteristics and medical conditions of each house-
hold resident by face-to-face interviews with a member
of each household. Respondents were asked whether
each household member had ever been diagnosed, by a
doctor or other health professional, as having certain
chronic clinical conditions including diabetes, asthma,
high blood pressure, coronary heart disease, angina,
myocardial infarction, stroke, emphysema, or joint
pain. In 2000, the MEPS for the first time also gathered
data using a self-administered questionnaire, which
was distributed to all individuals 18 years of age or
older in the sample. The questionnaire included the SF-
12 and the EQ-5D instruments.
Health-Related Quality of Life Measures
The EQ-5D descriptive system is a preference-based
HRQOL measure with one question for each of the
five dimensions that include mobility, self-care, usual
activities, pain/discomfort, and anxiety/depression
[17]. Each question has three levels of response (no
limitation, some limitation, severe or complete limita-
tion). An index score (EQ-5D index) also was calcu-
lated from the EQ-5D descriptive system using weights
recently provided by Shaw, Johnson, and Coons in the
US general population [18]. In addition to the multi-
dimensional descriptive system, the EQ-5D also
includes a separate 20 cm EQ-VAS to measure self-
assessed health status. Respondents are asked to rate
their health on a 101-point scale, the end-points of
which are labeled “best imaginable health state” and
“worst imaginable health state” anchored at 100 and
0, respectively [19].
The SF-12 is a shorter version of the Medical
Outcomes Study 36-Item Short-Form Health Survey
(SF-36) and consists of a subset of 12 items from the
SF-36. The SF-12 was constructed to reduce the
respondent burden of longer instruments used for
measuring HRQOL [20]. The 12 questions of the SF-
12 measure physical functioning, role limitations due
to physical problems, role limitations due to emo-
tional problems, pain, general health, vitality, social
functioning, and mental health. The SF-12 also
provides two summary scores, namely the Physical
Component Summary (PCS-12) and the Mental Com-
ponent Summary (MCS-12) [21]. The PCS-12 and the
MCS-12 are scored such that a higher score represents
better function, and each is standardized such that in
the general population, the mean score is 50 and the
standard deviation is 10 [21].
The SF-6D was derived from the SF-12 using the
algorithm provided by Brazier and Roberts [7]. The
SF-6D uses SF-12 data to classify individuals into a
six-dimensional health state classification system
where the dimensions are physical functioning, role
limitations, social functioning, pain, mental health,
and vitality. Each dimension has three to five levels and
thus, 7500 possible health states can be defined using
the SF-6D descriptive system. Brazier and Roberts also
provide valuations derived from a UK general popula-
tion to generate the SF-6D index score from the SF-6D
descriptive system [7].
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Study Sample
For this analyses, individuals of 18 years or older, with
responses on all items in the SF-12, EQ-5D descriptive
system, EQ-VAS, medical conditions, and sociodemo-
graphic characteristics, were included in the analysis.
Additional subgroup analyses were conducted on
respondents that reported no limitations on each of the
five dimensions of the EQ-5D descriptive system and
respondents that were classified in full health on each
of the six dimensions of the SF-6D descriptive system.
Data Analyses
Analyses were conducted using STATA version 8 and
SAS for Windows Version 8.2 [22,23]. All the analyses
incorporated sampling weights to account for the com-
plex survey design used in the MEPS. Although a select
subgroup was used in this study, the sample estimates
are representative of the US general population using
the subgroup analysis, as recommended in MEPS doc-
umentation [24]. In the MEPS, any subgroup with
greater than 100 observations can be used to support
national estimates [25]. Mean PCS-12 scores, MCS-12
scores, and EQ-VAS scores were calculated for the
sample. A checklist of nine medical conditions: angina,
asthma, diabetes, congestive heart disease, emphy-
sema, hypertension, joint pain, myocardial infarction,
and stroke were included in the MEPS. For analysis,
dichotomous variables were constructed indicating
presence or absence of each of the nine reported med-
ical conditions. Another variable to indicate the mean
number of chronic medical conditions also was con-
structed by summating responses on all nine medical
conditions.
To assess ceiling effects in the EQ-5D and the SF-6D
descriptive systems, respondents that reported no lim-
itations on all the five dimensions of EQ-5D were iden-
tified and their responses on the SF-6D descriptive
system were assessed. Similarly, respondents that were
classified in full health on all the six dimensions of SF-
6D were identified and their responses on EQ-5D
descriptive system were assessed.
Individuals that indicated full health on the EQ-5D
or the SF-6D descriptive systems were further classified
as being in better or worse health based on whether
their PCS-12 score, MCS-12 score or EQ-VAS score
was above or below the mean score on each of the
scales, respectively. In addition, individuals that indi-
cated full health on the EQ-5D descriptive system also
were classified as being in better or worse health based
on whether their SF-6D index score was above or
below the mean SF-6D index score. Similarly, individ-
uals with full health on the SF-6D descriptive system
also were classified as being in better or worse health
based on whether their EQ-5D index score was above
or below the mean EQ-5D index score. Individuals
classified as being in better health based on the above
scales were compared with those classified as being in
worse health on sociodemographic characteristics
including age, sex, marital status, employment status,
income,  number  of  years  of  education,  and  number
of chronic medical condition using chi-square tests of
associations or t-tests. Based on similar comparisons in
a previous study, we hypothesized that individuals that
were male, younger, more educated, with a higher
income, employed, married, and with lower number of
chronic medical conditions would more likely be clas-
sified in better health as opposed to worse health by a
more discriminative health measure [15].
Mean PCS-12, MCS-12, EQ-VAS, and SF-6D index
scores were calculated for individuals that reported full
health on the EQ-5D descriptive system and who
reported having no medical condition. Similarly, mean
PCS-12, MCS-12, EQ-VAS, and EQ-5D index scores
were calculated for individuals that reported full
health on the SF-6D descriptive system and reported
having no medical condition. T-tests were used to
compare the mean scale scores among respondents
who reported having specific medical conditions with
those who had no medical conditions. Effect sizes were
calculated for groups with statistical differences by
subtracting the mean for individuals with the medical
condition from the mean for individuals with no med-
ical condition and dividing by the standard deviation
of the mean for the sample. An a priori alpha level of
0.05 was used for statistical significance. No adjust-
ments were made for multiple comparisons because
effect sizes were used to assess if the differences
observed between groups were greater than the mini-
mum clinically important effect size of 0.2 [26].
Results
Sample Characteristics
A total of 11,248 individuals were 18 years or older
and had data on all the variables used in the study. A
total of 48 respondents (0.4%) were proxy respond-
ents in the data used in this study and were included in
the current analyses.
Of the 11,248 individuals, 5104 (47%) reported no
limitations on all the EQ-5D dimensions and 683
(5.8%) were classified in full health on all the SF-6D
dimensions. Table 1 provides the demographic charac-
teristics for the entire sample, respondents that
reported no limitations on all the EQ-5D dimensions
and respondents that were classified in full health on
all the SF-6D dimensions.
Approximately 33% of all respondents were
between the ages of 18 and 34 years (Table 1). The
majority of these individuals were white (86.2%), mar-
ried (57.5%), had a high school diploma (47.8%), and
employed (75.7%). The mean PCS-12 score among all
the respondents was 50.10 (SE = 0.13). The mean
MCS-12 score among all the respondents was 51.56
(SE = 0.12). The mean EQ-VAS score among all the
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respondents was 80.05 (SE = 0.22). Among all
respondents, the mean EQ-5D index score was 0.8739
(SE = 0.0022) and the mean SF-6D index score was
0.8126 (SE = 0.0017).
Among individuals that reported no limitations on
the EQ-5D descriptive system, approximately 42%
were between the ages of 18 and 34 years (Table 1).
The majority of these individuals were white (85.1%),
married (56.7%), had a high school diploma (45.9%),
and employed (84.3%).
Among individuals that were classified in full health
on the SF-6D, approximately 40% were between the
ages of 18 and 34 years (Table 1). The majority of
these individuals were white (77.2%), married
(50.4%), had a high school diploma (47.6%), and
employed (80.9%).
Distribution of Responses on the EQ-5D and the SF-6D 
Descriptive Systems
Table 2 provides the distribution of responses on the
EQ-5D descriptive system. A majority of the respond-
ents (more than 55%) indicated no limitations (level 1)
on at least one of the five EQ-5D dimensions. Very few
respondents (less than 4%) indicated severe limitations
(level 3) on any of the five dimensions of the EQ-5D.
Table 2 also shows the distribution of responses on the
SF-6D descriptive system. A large proportion of
respondents also were classified in the top category
(level 1) on the SF-6D for the dimensions of physical
functioning (81%), role limitation (74.5%), social
functioning (69.4%), and pain (57.4%). Very few
respondents (less than 4%) were classified in the bot-
tom category (level 5) on any of the six dimensions of
the SF-6D.
Assessing Ceiling Effects in the EQ-5D and the SF-6D 
Descriptive Systems
A total of 5104 individuals (47%) reported no limita-
tions on all the EQ-5D dimensions. Table 3 provides
distribution of responses on the SF-6D dimensions
among individuals who reported no limitations on all
the EQ-5D dimensions. In this group, a majority of
individuals were classified in level 1 for the SF-6D
dimension of physical functioning (97%), role limita-
tion (95.2%), social functioning (89.7%), and pain
(88.1%). Nevertheless, 84.2% of the respondents were
Table 1 Study sample characteristics
Category
Initial
sample
N = 11,248
Full Health
On EQ-5D
N = 5104
On SF-6D
N = 683 
Percent* Percent* Percent*
Age (years)
18–24 12.64 17.28 21.95
25–34 20.39 25.16 18.44
35–44 22.60 24.19 23.92
45–54 19.66 17.51 15.54
55–64 11.33 8.93 11.46
65–74 7.61 4.69 5.34
75 or above 5.77 2.24 3.35
Sex
Male 48.38 52.87 64.65
Female 51.62 47.13 35.35
Income (dollars)
Less than 10,000 22.95 19.65 22.43
10,000–30,000 36.84 34.05 37.40
30,000–50,000 22.45 25.09 19.54
50,000–70,000 10.58 12.32 12.00
More than 70,000 7.18 8.89 8.62
Education
No degree 14.28 11.16 18.60
GED 4.24 3.32 2.92
High school diploma 47.76 45.96 47.55
Bachelor’s degree 18.25 22.13 17.66
Master’s degree 6.81 7.82 6.38
Doctorate degree 1.81 2.43 2.89
Other degree 6.84 7.16 4.00
Race
Native American or Eskimo 0.86 8.85 2.26
Asian or Pacific Islander 3.21 3.99 4.69
African American 9.75 10.04 15.82
White 86.18 85.07 77.22
Hispanic ethnicity 9.50 10.61 19.02
Marital status
Married 57.52 56.71 50.40
Widowed 5.28 2.62 2.87
Divorced 11.07 9.06 10.68
Separated 1.72 1.73 2.14
Never married 24.41 30.54 33.91
Employment status
Employed at present 75.71 84.28 80.91
Not employed at present 24.29 15.72 19.09
*Percentages are weighted and account for the complex survey design of MEPS.
GED, general educational development.
Table 2 Proportion of responses (%) on each level of the EQ-5D and the SF-6D descriptive systems in the study sample (N = 11,248)
Sample distribution on scale dimensions
EQ-5D scale levels
(N = 11,248)
Mobility Self-care Usual
activities
Pain/
discomfort
Anxiety/
depression
1 83.9 97.2 83.8 55.6 73.6
2 15.8 2.6 15.0 41.0 24.3
3 0.2 0.2 1.2 3.3 2.2
SF-6D scale levels
(N = 11,248)
Physical
functioning
Role
limitation
Social
functioning
Pain Mental
health
Vitality
1 81.0 74.5 69.4 57.4 36.0 9.3
2 12.9 9.7 15.4 23.6 37.1 47.5
3 6.0 8.1 10.2 10.6 19.6 31.6
4 — 7.6 3.3 6.0 5.5 8.4
5 — — 1.7 2.4 1.8 3.2
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classified in level 2 or higher in the vitality dimension
and 49.2% of the respondents were classified in level 2
or higher in the mental health dimension.
A total of 683 individuals (5.8%) were classified in
full health on the SF-6D descriptive system. Further
analysis of this group revealed that a large majority,
628 (92.6%) had reported no limitations on all the
EQ-5D dimensions. Of the remaining 55 individuals
that reported limitations on the EQ-5D, 47 respond-
ents (6.2%) indicated some limitations, level 2, in the
pain dimension of EQ-5D, with less than eight
respondents reporting some or severe limitations in all
other dimensions.
Comparison of HRQOL Measures on Sociodemographic 
Characteristics for Individuals Reporting Full Health on 
EQ-5D Descriptive System
Table 4 compares individuals reporting no limitations
on the EQ-5D but classified as being in better or worse
health based on PCS-12, MCS-12, EQ-VAS, or SF-6D
index scores. Significant differences were observed in
most sociodemographic characteristics between indi-
viduals classified in better physical health and those
classified as in worse physical health based on PCS-12
score. As expected, individuals classified as in better
physical health were more likely to be men, employed,
younger, have a higher income, more educated and
have fewer chronic medical conditions than individu-
als classified in worse physical health.
Significant differences also were observed in some
of the sociodemographic characteristics between indi-
viduals classified in better mental health and worse
mental health based on MCS-12 score. As expected,
individuals classified as in better mental health were
more likely to be men and more likely to be married
than individuals classified in worse mental health.
Nevertheless, opposed to findings by Johnson and
Coons [15], individuals classified as in better mental
health were less likely to be employed than individuals
classified in worse mental health.
No significant differences were observed on any of
the sociodemographic characteristics among indivi-
duals classified in better or worse health based on the
EQ-VAS score. Nevertheless, as expected, individuals
classified in better health based on EQ-VAS had
Table 3 Ceiling effects of EQ-5D. Distribution of responses
(%) on the SF-6D dimensions for those with EQ-5D = 11111
(N = 5104)
Level
Physical
functioning
Role
limitation
Social
functioning Pain
Mental
health Vitality
1 97.0 95.2 89.7 88.1 50.8 15.8
2 2.3 1.9 8.1 10.4 37.2 61.2
3 0.7 2.6 1.3 1.0 8.8 20.6
4 — 0.3 0.5 0.3 1.4 1.5
5 — — 0.5 0.2 1.9 1.0
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significantly lower mean number of chronic medical
conditions compared with individuals classified in
worse health (0.35 vs. 0.54).
There were significant differences on some sociode-
mographic characteristics among individuals classified
in better or worse health based on the SF-6D index
score. As expected, individuals classified in better
health based on the SF-6D index score were more
likely to be men, have a higher income and married
compared with individuals classified in worse health.
Nevertheless, contrary to expectation, individuals clas-
sified in better health based on SF-6D index score were
significantly older compared with individuals classified
in worse health (Table 4).
Comparison of HRQOL Measures on Sociodemographic 
Characteristics for Individuals Classified in Full Health on 
SF-6D Descriptive System
Among individuals classified in full health on the SF-
6D descriptive system, only three individuals could be
classified as in better physical health (PCS-12 score
higher than the mean PCS-12 score), as a result, no
comparisons were made between better physical health
and worse physical health. Similarly, only five individ-
uals out of the 683 individuals (in full health on SF-
6D) could be classified as in better mental health based
on the MCS-12, as a result, no comparisons were made
between better mental health and worse mental health
in those groups.
Based on EQ-VAS score being higher than the mean
EQ-VAS score, 92 out of 683 individuals (in full health
on SF-6D) were classified in better health. Further
analysis of this group found no significant differences
on most of the sociodemographic characteristics
among individuals classified in better or worse health
based on the EQ-VAS score. Nevertheless, individuals
classified in better health based on EQ-VAS compared
with individuals classified in worse health had signifi-
cantly higher number of years of education (13.1 vs.
11.9 years), a higher proportion of employed individ-
uals (82.6% vs. 67.9%), and individuals with higher
incomes ($32,516 vs. $20,687).
Based on the EQ-5D index score being higher than
the mean EQ-5D index score, 55 out of 683 individ-
uals (in full health on SF-6D) were classified in better
health. Further analysis of this group found no signif-
icant differences on most of the sociodemographic
characteristics among individuals classified in better or
worse health based on the EQ-5D index score. Never-
theless, individuals classified in better health based on
EQ-5D index score compared with individuals classi-
fied in worse health were significantly younger
(39.5 vs. 47.9 years).
Comparison of HRQOL Measures on Medical Conditions 
for Individuals Reporting Full Health on EQ-5D 
Descriptive System
Among individuals that indicated no limitations on the
EQ-5D were individuals that reported having a diag-
nosis of coronary heart disease, angina, stroke, diabe-
tes, myocardial infarction, high blood pressure, joint
pain, asthma, or emphysema (14 respondents). A total
of 3523 individuals (69.4%) among those that
reported full health on EQ-5D descriptive system
reported having no medical condition. Table 5 pro-
vides a comparison of PCS-12 scores, MCS-12 scores,
EQ-VAS scores, and SF-6D index scores between indi-
viduals that reported having a specific medical condi-
tion and those that reported having no medical
condition. Data are presented only for the medical
Table 5 Comparison of mean (SE) scores on SF-12, SF-6D index, and EQ-VAS among individuals with chronic conditions and those
with no medical conditions for individuals reporting no limitations on the EQ-5D
Condition n PCS-12 MCS-12 SF-6D EQ-VAS
No medical condition 3523 55.28 (0.06) 54.95 (0.06) 0.8852 (0.0015) 88.44 (0.27)
Coronary heart disease 51 51.54 (1.06)* 56.85 (0.86)† 0.8819 (0.0102) 80.62 (2.28)*
Effect size‡ 0.92 0.34 0.45
Angina 30 51.71 (0.84)* 55.55 (1.01) 0.8726 (0.0122) 82.43 (1.92)§
Effect size 0.88 0.34
Stroke 31 52.07 (0.91)* 54.92 (1.23) 0.8707 (0.0108) 84.29 (2.34)
Effect size 0.79
Diabetes 165 52.28 (0.42)* 55.59 (0.42) 0.8854 (0.0073) 79.86 (1.48)*
Effect size 0.74 0.49
Myocardial infarction 55 52.34 (0.43)* 55.68 (0.87) 0.8807 (0.0095) 79.59 (1.74)*
Effect size 0.72 0.51
High blood pressure 658 53.48 (0.19)* 55.62 (0.23)† 0.8853 (0.0031) 84.34 (0.49)*
Effect size 0.44 0.12 0.23
Joint pain 730 54.25 (0.15)* 55.09 (0.19) 0.8837 (0.0032) 85.72 (0.52)*
Effect size 0.25 0.16
Asthma 333 54.56 (0.27)* 54.31 (0.37)§ 0.8755 (0.0040) 87.00 (0.63)
Effect size 0.18 0.12
*Group means are statistically different in expected direction with P-value <0.001.
†Group means are statistically different in nonexpected direction with P-value <0.05.
‡Effect size were calculated by subtracting the mean for individuals with the condition from the mean for individuals without any medical condition and dividing by the standard
deviation (SD) of the mean for the whole sample (N = 5104). SD of PCS-12 was 4.08, SD of MCS-12 was 5.53 and SD of EQ-VAS was 17.49.
§Group means are statistically different in expected direction with P-value <0.05.
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conditions with 30 or more observations to maintain
stability of the standard errors of estimates.
Individuals who reported having coronary heart
disease, angina, stroke, diabetes, myocardial infarc-
tion, high blood pressure, joint pain or asthma had sig-
nificantly lower mean PCS-12 scores than individuals
who reported having no medical condition. Effect sizes
using the PCS-12 ranged from 0.18 for asthma to 0.92
for coronary heart disease, most of them were above
the minimum clinically important effect size of 0.2
[26].
Mean scores on the MCS-12 were significantly
lower for individuals with asthma compared with indi-
viduals with no medical condition. Nevertheless, mean
scores on the MCS-12 were not significantly different
between individuals that reported most other medical
conditions and those that did not have any medical
condition. Furthermore, contrary to expectations,
individuals who reported having coronary heart dis-
ease or high blood pressure had significantly higher
mean scores on MCS-12 compared with individuals
having no medical condition (Table 5).
Mean scores on the SF-6D index score were not sig-
nificantly different between individuals that reported
having a medical condition and those that did not have
any medical condition (Table 5). Individuals who
reported having coronary heart disease, diabetes, myo-
cardial infarction, high blood pressure or joint pain
also had significantly lower mean EQ-VAS scores, than
individuals who reported having no medical condition.
Effect sizes using the EQ-VAS ranged from 0.16 for
pain to 0.51 for myocardial infarction (Table 5).
Comparison of HRQOL Measures on Medical Conditions 
for Individuals Classified in Full Health on SF-6D 
Descriptive System
Among individuals that were classified in full health
on the SF-6D were individuals that reported having
a diagnosis of high blood pressure, asthma, joint
pain, diabetes (16 respondents), myocardial infarc-
tion (five respondents), stroke (four respondents),
coronary heart disease (three respondents) or angina
(one respondent). A total of 522 respondents
(76.43%) in this group reported having no medical
condition. Table 6 provides a comparison of PCS-12
scores, MCS-12 scores, EQ-VAS scores, and EQ-5D
index scores between individuals that reported
having a specific medical condition and those that
reported having no medical condition. Data are pre-
sented only for the medical conditions with 30 or
more observations.
Individuals who reported having high blood pres-
sure had significantly lower mean PCS-12 scores than
individuals who reported having no medical condition.
Effect size using the PCS-12 was 0.52 for high blood
pressure. Mean scores on the MCS-12, EQ-5D index
or the EQ-VAS were not significantly different between
individuals that reported any of the three medical con-
ditions and those that reported having no medical con-
dition (Table 6).
Discussion
This analysis compared two widely used generic
health-related quality of life measures to assess their
ceiling effects in the US general population. To our
knowledge, this is the first such comparison of the SF-
6D derived from the SF-12 and the EQ-5D. The study
provides evidence suggesting that the EQ-5D descrip-
tive system compared with the SF-6D descriptive sys-
tem derived from the SF-12 has a substantial ceiling
effect in the US general population. Out of the 11,248
individuals in the study sample, a large proportion,
5104 (47%) reported full health on the EQ-5D dimen-
sions. Nevertheless, only 683 respondents, 5.8% of the
study sample were classified in full health on the SF-
6D. Such a distribution of responses on the EQ-5D
descriptive system has been observed in the United
States, UK, Canadian, and Catalan general population
surveys [12–15].
A great majority of those reporting full health on
the EQ-5D descriptive system were not classified in full
health on the SF-6D descriptive system. Based on the
SF-6D responses, individuals reporting full health on
the EQ-5D may still have problems on the mental
health function and vitality dimensions. Of particular
interest is that of those who reported no limitations on
the EQ-5D, 49.2% of the respondents reported feeling
“tense or downhearted and low” a little (level 2) or
some (level 3) of the time.
Table 6 Comparison of mean (SE) scores on SF-12, EQ-5D, and EQ-VAS among individuals with chronic conditions and those with
no medical conditions for individuals reporting no limitations on the SF-6D
Condition n PCS-12 MCS-12 EQ-5D EQ-VAS
No medical condition 522 56.16 (0.07) 59.97 (0.08) 0.9888 (0.0025) 92.87 (0.56)
High blood pressure 60 55.30 (0.18)* 60.20 (0.13) 0.9845 (0.0065) 91.52 (1.32)
Effect size† 0.52
Asthma 31 55.65 (0.29) 60.18 (0.24) 0.9847 (0.0088) 93.10 (1.49)
Joint pain 83 55.90 (0.18) 60.03 (0.17) 0.9792 (0.0063) 91.64 (1.11)
*Group means are statistically different in expected direction with P-value <0.001.
†Effect size was calculated by subtracting the mean for individuals with the condition from the mean for individuals without any medical condition and dividing by the standard
deviation (SD) of the mean for the whole sample (N = 683). SD of PCS-12 was 1.66.
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Johnson and Coons compared the EQ-5D and SF-
12 in an adult US sample [15]. In their study, 206 of
413 respondents (49.88%) indicated no limitations on
all the EQ-5D dimensions. Among individuals report-
ing no limitations on EQ-5D, they found that respond-
ents reporting poorer physical health (below median
PCS-12 score) were older and were less likely to be
married or employed than those in the better health
group. The worse mental health group (below median
PCS-12 score) had a higher proportion of women and
persons not married or in a partnership. They also
found that respondents with worse health on both
components had more chronic medical conditions on
average and had lower mean EQ-VAS scores than sub-
jects in the better health groups. The results of our
study were mostly consistent with the findings by
Johnson and Coons [15]. Nevertheless, the Johnson
and Coons study did not find statistically significant
differences in the evaluation of the effect of specific
chronic medical conditions on the SF-12 component
scores for these subjects, primarily resulting from the
small sample sizes. In addition, the study did not com-
pare individuals in better or worse health based on the
EQ-VAS scores. We found statistically significant dif-
ferences in the evaluation of the effect of specific med-
ical conditions on the PCS-12 scores and the EQ-VAS
scores for individuals that reported no limitations on
all EQ-5D dimensions. In addition, our study evalu-
ated the effect sizes for specific medical conditions
using the PCS-12, the MCS-12, and the EQ-VAS to
compare their discriminative ability.
Among individuals who reported full health on the
EQ-5D, mean scores on PCS-12 were significantly
lower for those who reported having coronary heart
disease, angina, stroke, diabetes, myocardial infarc-
tion, high blood pressure, joint pain or asthma than
individuals who reported having no medical condition.
Effect sizes using the PCS-12 ranged from 0.18 for
asthma to 0.92 for coronary heart disease. Among
individuals who reported full health on the EQ-5D,
mean scores on EQ-VAS were significantly lower for
those who reported having coronary heart disease,
angina, diabetes, myocardial infarction, high blood
pressure or joint pain than individuals who reported
having no medical condition. Effect sizes using the EQ-
VAS ranged from 0.16 for joint pain to 0.51 for myo-
cardial infarction. These findings indicate that individ-
uals with significant morbidity are misclassified as in
full health on the EQ-5D descriptive system, when in
fact they have substantially lower health-related qual-
ity of life compared with individuals without any med-
ical condition. The findings also indicate that the effect
sizes using PCS-12 were higher than those using EQ-
VAS providing evidence of the better discriminative
ability of the PCS-12 compared with the EQ-VAS.
Among individuals that were classified in full health
on the SF-6D descriptive system, fewer individuals
reported having a medical condition. Further in most
cases, statistically significant differences were not
found using the PCS-12, the MCS-12, or the EQ-VAS
among individuals who were classified in full health on
the SF-6D and reported having a specific medical con-
dition compared with those that reported having no
medical condition. Although, the SF-6D descriptive
system derived from the SF-12 did not seem to have a
ceiling effect as did the EQ-5D descriptive system, the
SF-6D index did not discriminate among individuals
who reported full health on the EQ-5D and reported
having a specific medical condition compared with
those that reported having no medical condition. It is
likely that this lack of significant difference in SF-6D
index score among groups may be due to the use of
preference weights for constructing the SF-6D index
scores that were derived in the UK general population
[7], rather than the US general population. It is recom-
mended that future studies are conducted to derive
preference weights for the SF-6D descriptive system for
the US general population.
Some of the findings in our study were not in the
expected direction. For example, among individuals
who reported no limitations on EQ-5D, individuals
who reported having coronary heart disease or high
blood pressure, had a higher MCS-12 score than indi-
viduals without medical conditions. Furthermore, no
clinically important differences were observed in the
MCS-12 between individuals with any of the other
chronic medical conditions and those without a med-
ical condition. Some researchers have suggested that
the RAND-12 scoring approach [27] offers several the-
oretical advantages over the SF-12 scoring algorithm
in terms of performance of the summary scores in dis-
criminating between known groups [28,29]. Neverthe-
less, we also conducted all the analyses described in
this study using the RAND-12 scoring algorithm, but
the trends across all results remained. The MHC-12
(Mental Health Composite of the RAND-12) also did
not find significant differences between individuals
with chronic medical conditions and those without a
medical condition. Thus, this result does not appear to
be due to the differences in scoring algorithms used to
construct the SF-12 and RAND-12 component sum-
mary scores [28–31], but is more likely due to the fact
that most of the chronic medical conditions included in
the study would have a primary impact on individuals’
physical functioning rather than mental functioning.
Other studies also have reported ceiling effects in
EQ-5D descriptive system. Brazier et al. compared the
EQ-5D and an Anglicized version of the SF-36 in a
postal survey of patients from two primary care prac-
tices in the UK [32]. They concluded that the SF-36
provides a more sensitive description of health across
the dimensions compared with the EQ-5D and may be
more useful for measuring health in populations with
less severe morbidity. The authors observed a large
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ceiling effect in the EQ-5D suggesting that EQ-5D
would be more suitable for measuring the health of
populations with more morbidity, where the distribu-
tion of responses is less skewed. Nevertheless, studies
conducted in morbid populations, also have found
some evidence of ceiling effect in the EQ-5D [33–35].
In a study of patients with Hodgkin’s disease [33], 19
of 49 patients reported the maximum level of health
for all the five items of the EQ-5D, whereas in a study
of patients with advanced HIV disease [34], 30%
reported no limitations in all dimension of EQ-5D.
There are several possible reasons for the ceiling
effect observed in the EQ-5D descriptive system. The
EQ-5D dimensions are limited to three response cate-
gories per item and this may consequently lead it to
having a ceiling effect [12]. It may be that three
response choices per dimension do not allow it to cap-
ture variations among individuals. In contrast, the SF-
6D derived from the SF-12 has levels ranging from
three to five which makes it more sensitive to differ-
ences among individuals. The exclusion of some
important health-related quality of life dimensions
may be responsible for the observed ceiling effect
[13,14,35]. For example, the vitality dimension which
is an additional dimension in the SF-6D, is not in the
EQ-5D. In this study, 31.6% of the respondents that
reported full health on the EQ-5D reported having “a
lot of energy” some (level 3) of the time.
In conclusion, although the EQ-5D descriptive sys-
tem was created with simplicity as a central require-
ment it may suffer from ceiling effects in general
populations. The study results also suggest that
although the SF-6D descriptive system derived from
the SF-12 does not seem to have a ceiling effect, the SF-
6D index score, unlike the PCS-12 and the EQ-VAS,
was not able to discriminative between groups with
varying morbidity, among those who reported full
health on the EQ-5D. In addition, the PCS-12 was
more discriminating than the EQ-VAS as a self-rating
HRQOL measure. Between the PCS-12 and the EQ-
VAS, in addition to discriminating between individuals
with chronic medical conditions with higher effect
sizes, the PCS-12 was also able to discriminate
between individuals with different sociodemographic
characteristics. These findings may be important when
considering which measures to use to assess HRQOL
in general populations.
Source of financial support: None.
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